On March 16-19, 2025, we presented our data on "Proteogenomic characterization of leukemia cells resistant to combined therapy with Azacitidine and Pevonedistat reveals activation of autophagy via the SQSTM1-NRF2 axis" at the world conference Acute Leukemias XIX in Munich, Germany.